We’re able to obtain an Unique Entity Identifier.
On May 16, 2023, we have obtained a Unique Entity Identifier (UEI), which allows us to receive grants and assi […]
We’re able to obtain an Unique Entity Identifier. Read More »
We’re able to obtain an NCAGE CODE number.
We are pleased to announce that we have obtained the NCAGE code “JB211” as of April 18, 2023. The
We’re able to obtain an NCAGE CODE number. Read More »
We started AGI (Artificial General Intelligence) development this year
We are pleased to announce that we will begin developing/providing AGI (Artificial General Intelligence) this
We started AGI (Artificial General Intelligence) development this year Read More »
we Selected as one of the 10 finalists for the 31st General Assembly of the Japanese Association of Medical Sciences Exposition x CIC
The 31st General Assembly of the Japanese Association of Medical Sciences Exposition x CIC we Selected as one
AI Generated Advanced Research & Development NCC (National Cancer Center) Concluded Joint Research, And Development Agreement With NOVIUS ( Media Articles Published In Japan
―ObjectThe objective of this project is to improve the accuracy of diagnosis by using AI technology to convert
Certified Intel® Alliance Partner
Intel partners have a long history of innovation and the Intel® Partner Alliance helps accelerate solution bui
Certified Intel® Alliance Partner Read More »
Our article was published in the journal Medical Science Digest, which is published in Japan.
Haruhiko Ogata (Keio University Endoscopy Center) serves as a special advisor for the August 2022 issue of 
Adopted by Microsoft for Startups
(Head office: Hachioji City, Tokyo; CEO: Tomoko Fujino; hereinafter “NOVIUS”), a technology that e
Adopted by Microsoft for Startups Read More »
